Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Sinohealth Holdings Ltd. ( (HK:2361) ) just unveiled an announcement.
Sinohealth Technology Holdings Limited has disclosed that its public float stands at about 16.45%, below the 25% minimum required under Hong Kong Listing Rules, largely because 8.84% of its shares are held by a trustee for ungranted share awards and therefore excluded from the public float calculation. The current shareholding structure shows significant stakes held by several major shareholders, leaving a relatively small portion in the hands of public investors, which keeps the company in temporary non-compliance with the exchange’s public float requirements.
To address this, the company plans to grant the remaining share awards over the next three years based on corporate performance and individual appraisals, targeting at least 2% of total share capital in awards annually to non-core connected persons. In parallel, Sinohealth aims to boost its public float by at least eight percentage points by the end of June 2027 via equity financing and potential selldowns by major shareholders, while committing to monthly updates and adherence to additional listing rule obligations until full compliance is restored.
More about Sinohealth Holdings Ltd.
Sinohealth Technology Holdings Limited is a Cayman Islands-incorporated company listed in Hong Kong, operating in the healthcare data and technology sector. The company has implemented a share award scheme as part of its long-term incentive strategy, with a portion of its issued share capital held in trust for future grants to eligible participants, including non-core connected persons.
Average Trading Volume: 15,377
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.12B
For a thorough assessment of 2361 stock, go to TipRanks’ Stock Analysis page.